Intelligence Platform
Patents
Browse 774 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7432300
Gossypol co-crystals and the use thereof
granted patentUS 7429238
Systems and methods for the generation of crystalline polymorphs
granted patentUS 7427602
Sustained DNA delivery from structural matrices
granted patentUS 7422900
System and method for forming a connective tissue construct
granted patentUS 7416741
Copper lowering treatment of inflammatory and fibrotic diseases
granted patentUS 7416724
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
granted patentUS 7414035
hKIS composition and methods of use
granted patentUS 7393855
2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrimidines as antiviral agents
granted patentUS 7388074
Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof
granted patentUS 7387881
Detection and treatment of cancers of the liver
granted patentUS 7387896
MicroRNA vectors
granted patentUS 7375086
Modulators of Nod2 signaling
granted patentUS 7371575
Process for ex vivo formation of mammalian bone and uses thereof
granted patentUS 7368279
Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor
granted patentUS 7354928
Small molecule inhibitors targeted at Bcl-2
granted patentUS 7344722
Cold-adapted influenza virus
granted patentUS 7341871
Nucleotide sequences for gene regulation and methods of use thereof
granted patentUS 7342046
Gossypol co-crystals and the use thereof
granted patentUS 7338798
System and method for forming a cardiac muscle construct
granted patentUS 7335383
Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in bl
granted patentUS 7335681
Amino ceramide-like compounds and therapeutic methods of use
granted patentUS 7332287
Methods and compositions for diagnosing breast cancer
granted patentUS 7329638
Drug delivery compositions
granted patentUS 7323171
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
granted